These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16511526)
1. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526 [TBL] [Abstract][Full Text] [Related]
2. Shark protein improves bone mineral density in ovariectomized rats and inhibits osteoclast differentiation. Uehara K; Takahashi A; Watanabe M; Nomura Y Nutrition; 2014 Jun; 30(6):719-25. PubMed ID: 24800672 [TBL] [Abstract][Full Text] [Related]
4. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509 [TBL] [Abstract][Full Text] [Related]
5. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Shu G; Yamamoto K; Nagashima M Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo. Kunugiza Y; Tomita T; Tomita N; Morishita R; Yoshikawa H Arthritis Res Ther; 2006; 8(4):R103. PubMed ID: 16813665 [TBL] [Abstract][Full Text] [Related]
7. CpG oligonucleotides: novel regulators of osteoclast differentiation. Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977 [TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. Amcheslavsky A; Bar-Shavit Z J Cell Physiol; 2006 Apr; 207(1):244-50. PubMed ID: 16402377 [TBL] [Abstract][Full Text] [Related]
9. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats. Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877 [TBL] [Abstract][Full Text] [Related]
10. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing. Shimizu H; Nakagami H; Morita S; Tsukamoto I; Osako MK; Nakagami F; Shimosato T; Minobe N; Morishita R Antioxid Redox Signal; 2009 Sep; 11(9):2065-75. PubMed ID: 19186992 [TBL] [Abstract][Full Text] [Related]
11. Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Penolazzi L; Lambertini E; Borgatti M; Piva R; Cozzani M; Giovannini I; Naccari R; Siciliani G; Gambari R Biochem Pharmacol; 2003 Oct; 66(7):1189-98. PubMed ID: 14505798 [TBL] [Abstract][Full Text] [Related]
13. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830 [TBL] [Abstract][Full Text] [Related]
14. NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model. Lin TH; Pajarinen J; Sato T; Loi F; Fan C; Córdova LA; Nabeshima A; Gibon E; Zhang R; Yao Z; Goodman SB Acta Biomater; 2016 Sep; 41():273-81. PubMed ID: 27260104 [TBL] [Abstract][Full Text] [Related]
15. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model. Miyake T; Aoki M; Morishita R Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844 [TBL] [Abstract][Full Text] [Related]
18. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265 [TBL] [Abstract][Full Text] [Related]
19. Differential β3 and β1 Integrin Expression in Bone Marrow and Cortical Bone of Estrogen Deficient Rats. Voisin M; McNamara LM Anat Rec (Hoboken); 2015 Sep; 298(9):1548-59. PubMed ID: 25974241 [TBL] [Abstract][Full Text] [Related]
20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]